Nasus Pharma Ltd — All Filings
72 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
20-F
3
424B4
6-K
8-A12B
CERT
CORRESP
D
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
FWP
POS AM
SCHEDULE 13G
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 3 | 3 | 0001493152-26-013399 | Mar 27, 2026 | Mar 18, 2026 |
| 3 | 3 | 0001493152-26-013388 | Mar 27, 2026 | Mar 18, 2026 |
| 3 | 3 | 0001493152-26-013389 | Mar 27, 2026 | Mar 18, 2026 |
| 3 | 3 | 0001493152-26-013387 | Mar 27, 2026 | Mar 18, 2026 |
| 3 | 3 | 0001493152-26-013383 | Mar 27, 2026 | Mar 18, 2026 |
| 3 | 3 | 0001493152-26-013384 | Mar 27, 2026 | Mar 18, 2026 |
| 3 | 3 | 0001493152-26-013386 | Mar 27, 2026 | Mar 18, 2026 |
| 3 | 3 | 0001493152-26-013385 | Mar 27, 2026 | Mar 18, 2026 |
| POS AM | POS AM | 0001493152-26-013287 | Mar 27, 2026 | — |
| 6-K | 6-K | 0001493152-26-012663 | Mar 25, 2026 | — |
| 20-F | 20-F | 0001493152-26-012559 | Mar 25, 2026 | Dec 31, 2025 |
| 6-K | 6-K | 0001493152-26-010189 | Mar 16, 2026 | — |
| EFFECT | — | 9999999995-26-000817 | Mar 13, 2026 | — |
| 6-K | 6-K | 0001493152-26-009135 | Mar 6, 2026 | — |
| 6-K | 6-K | 0001493152-26-008780 | Mar 4, 2026 | — |
| F-1 | F-1 | 0001493152-26-008581 | Mar 2, 2026 | — |
| D | — | 0001493152-26-008057 | Feb 25, 2026 | — |
| 6-K | 6-K | 0001493152-26-007802 | Feb 24, 2026 | Feb 23, 2026 |
| 6-K | 6-K | 0001493152-26-006565 | Feb 13, 2026 | — |
| 6-K | 6-K | 0001493152-26-006265 | Feb 12, 2026 | Feb 11, 2026 |
| 6-K | 6-K | 0001493152-26-004233 | Jan 29, 2026 | — |
| 6-K | 6-K | 0001493152-26-002755 | Jan 20, 2026 | — |
| 6-K | 6-K | 0001493152-25-029210 | Dec 29, 2025 | Jun 30, 2025 |
| 6-K | 6-K | 0001493152-25-028664 | Dec 22, 2025 | — |
| 6-K | 6-K | 0001493152-25-024400 | Nov 20, 2025 | — |
| 6-K | 6-K | 0001493152-25-023992 | Nov 18, 2025 | — |
| SCHEDULE 13G | — | 0001493152-25-022144 | Nov 13, 2025 | — |
| SCHEDULE 13G | — | 0001493152-25-021898 | Nov 12, 2025 | — |
| SCHEDULE 13G | — | 0001493152-25-021552 | Nov 10, 2025 | — |
| 6-K | 6-K | 0001493152-25-020540 | Nov 3, 2025 | — |
| 6-K | 6-K | 0001493152-25-017378 | Oct 8, 2025 | — |
| 6-K | 6-K | 0001493152-25-016290 | Sep 30, 2025 | — |
| 6-K | 6-K | 0001493152-25-012675 | Sep 5, 2025 | — |
| SCHEDULE 13G | — | 0001178913-25-003007 | Aug 20, 2025 | — |
| 6-K | 6-K | 0001493152-25-011984 | Aug 14, 2025 | — |
| 424B4 | 424B4 | 0001641172-25-023826 | Aug 14, 2025 | — |
| EFFECT | — | 9999999995-25-002578 | Aug 12, 2025 | — |
| CERT | NYSE AMERICAN CERTIFICATION | 0001143313-25-000055 | Aug 12, 2025 | — |
| CORRESP | — | 0001493152-25-011757 | Aug 8, 2025 | — |
| CORRESP | — | 0001493152-25-011755 | Aug 8, 2025 | — |
| 8-A12B | 8-A12B | 0001493152-25-011753 | Aug 8, 2025 | — |
| CORRESP | — | 0001493152-25-011715 | Aug 7, 2025 | — |
| F-1/A | F-1/A | 0001493152-25-011714 | Aug 7, 2025 | — |
| UPLOAD | — | 0000000000-25-008259 | Aug 6, 2025 | — |
| FWP | FWP | 0001493152-25-011504 | Jul 30, 2025 | — |
| FWP | FWP | 0001493152-25-011447 | Jul 28, 2025 | — |
| CORRESP | — | 0001493152-25-011445 | Jul 28, 2025 | — |
| F-1/A | F-1/A | 0001493152-25-011444 | Jul 28, 2025 | — |
| UPLOAD | — | 0000000000-25-007481 | Jul 16, 2025 | — |
| F-1 | F-1 | 0001641172-25-018388 | Jul 9, 2025 | — |